K. Kobayashi

Saitama International Medical Center

Publishes on Lung Cancer Treatments and Mutations, Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies. 7 papers and 32 citations.

7Publications

32Total Citations

Lung Cancer Treatments and Mutations Gastric Cancer Management and Outcomes Colorectal Cancer Treatments and Studies Lung Cancer Diagnosis and Treatment HER2/EGFR in Cancer Research

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

PL03.13 Osimertinib With/Without Platinum-Based Chemotherapy as First-line Treatment in Patients with EGFRm Advanced NSCLC (FLAURA2)

Pasi A. Jänne, D. Planchard, Ying Cheng et al.|Journal of Thoracic Oncology|2023

Cited by 10Open Access

PL02.06 First-Line Osimertinib + Chemotherapy Versus Osimertinib Monotherapy in EGFRm Advanced NSCLC: FLAURA2 Final Overall Survival

D. Planchard, P.A. Jänne, K. Kobayashi et al.|Journal of Thoracic Oncology|2025

Cited by 10

MA12.04 FLAURA2: Impact of Tumor Burden on Outcomes of 1L Osimertinib ± Chemotherapy in Patients with EGFR-mutated Advanced NSCLC

Natalia Valdiviezo, J.E. Gray, Pasi A. Jänne et al.|Journal of Thoracic Oncology|2024

Cited by 9Open Access

LBA77 FLAURA2: Exploratory overall survival (OS) analysis in patients (pts) with poorer prognostic factors treated with osimertinib (osi) ± platinum-pemetrexed chemotherapy (CTx) as first-line (1L) treatment (tx) for EGFR-mutated (EGFRm) advanced NSCLC

P.A. Jänne, D. Planchard, K. Kobayashi et al.|Annals of Oncology|2025

Cited by 3Open Access

Randomized Phase Ii Study of Concurrent Versus Sequential Alternating Gefitinib and Chemotherapy in Previously Untreated Non-Small Cell Lung Cancer (Nsclc) with Sensitive Egfr Mutations: Nej005/Tcog0902

O. Ishimoto, S. Oizumi, K. Minato et al.|Annals of Oncology|2014

Cited by 1Open Access